Long-form, evidence-first breakdowns — training, nutrition, recovery, and research literacy. Every claim traced to the paper it came from.
POLICY · PEPTIDESOn October 28, 2026, HHS filed a policy letting pharmacies compound six unapproved peptides without fear of FDA enforcement. The science didn't change. The enforcement posture did. The six peptides, the one left out, the three distinctions that carry the story — and what still hasn't been answered.
Read the article → MYOSTATIN · MUSCLE BIOLOGYA September 2026 study grew dramatically bigger muscles in diseased mice — and the muscles didn't get any stronger. Mass went up, force didn't, and the growth vanished weeks after treatment stopped. What the experiment actually proves, what it doesn't, and why the field's new standard is contractile performance, not bulk.
Read the article → HYPERTROPHY · TRAININGMore sets grow more muscle — on average. But the curve bends hard, every set charges fatigue, and the "optimal" number depends on the lifter. The full evidence review: dose-response data, proximity to failure, frequency, individual variability, and a practical decision flowchart.
Read the article →